We develop cutting-edge membrane technologies for high-resolution nanofiltration.
TeraPore Technologies is a venture-backed company that is commercializing cutting-edge membrane technologies. Its mission is to solve the most challenging bioseparations problems through the development and use of high-permeability, high-resolution membrane nanofiltration systems for bioprocessing and other applications, across a wide range of industries.
TeraPore was founded in 2013 as a spinout of Cornell University, and has received support from the National Institutes of Health (NIH), the National Science Foundation (NSF), and the Defense Threat Reduction Agency (DTRA).
Customizable Pore Sizes
TeraPore develops and manufactures filters with unprecedented performance through a proprietary and scalable block copolymer self-assembly technology. When fabricated into membranes, the polymers spontaneously form into highly uniform structures, creating precise holes (or pores) on the nanoscale. The benefits of these membranes include high permeability, allowing very fast flow rates, and uniform pore sizes for extremely precise nanofiltration.
TeraPore’s engineered membranes are manufactured at scale and at a range of different pore sizes – unique characteristics that are unprecedented in the field of nanofiltration.
One critical application for Terapore’s technology is in the production process of biological drugs (or biologics) where a key step is the separation of viral contaminants from the drug material.
Beyond the biotech industry, TeraPore’s products have utility in water treatment, semiconductor processing, and responsive fabrics.
Chief Commercial Officer
Board of Directors
Dr. Stuart Berkowitz
Dr. Rachel Dorin
Dr. Mark Plavsic
Dr. Mark Hurwitz
Dr. Neil Schauer
Dr. Stephen Turner
July 24, 2018
July 24, 2018 – TeraPore Technologies, the developer of advanced nanofiltration membrane systems for bioprocess and other applications, today announced that Marty Siwak has joined the company as its first Chief Commercial Officer. In this new role, Marty will oversee the continued development and commercialization of TeraPore’s proprietary block copolymer nanofiltration membrane technology…
March 6, 2018
March 6, 2018 – TeraPore Technologies, the developer of advanced nanofiltration membrane systems for bioprocess and other applications, today announced that it has completed a $6M Series A financing round. The round was led by Anzu Partners and includes RA Capital Management and Artiman Ventures. Company counsel Wilson Sonsini Goodrich & Rosati also participated…